You just read:

Oncothyreon Obtains Anti-Bcl-2 Compound from Sanford-Burnham Medical Research Institute; License Will Expand Oncology Product Development Pipeline

News provided by

Oncothyreon Inc.

Sep 12, 2011, 08:00 ET